drugset / Trial / NCT06049108
A Study of Carbon-14-Labelled [14C] LY3871801 in Healthy Male Participants
Non-randomizedSingle-groupOpen-labelBasic science
Summary
The main purpose of this study is to evaluate how much of the study drug (LY3871801), administered as a single dose that has the radioactive substance 14C incorporated into it, passes from blood into urine, feces and expired air in healthy male participants. The study will also measure how much of the study drug gets into the bloodstream, how its broken down, and how long it takes the body to get rid of it. The study will last up to approximately 9 weeks including the screening period.
Timeline
- Start
- 2023-09-15
- Primary completion
- 2023-11-03
- Completion
- 2023-11-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | OCADUSERTIB | Small molecule | — | Oral |
Indications
No indication recorded.